Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: The role of promoter methylation of TSC genes

This publication has 35 references indexed in Scilit:

• Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat
  Carcinogenesis: Integrative Cancer Research, 2003
• Polycystic Kidney Disease as a Result of Loss of the Tuberous Sclerosis 2 Tumor Suppressor Gene During Development
  The American Journal of Pathology, 2003
• Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system.
  Human Molecular Genetics, 2002
• Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosis
  Proceedings of the National Academy of Sciences, 2000
• Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background
  Journal of Clinical Investigation, 1999
• Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development
  Proceedings of the National Academy of Sciences, 1998
• Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
  Science, 1997
• Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas
  Annals of Neurology, 1997
• The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis
  Journal of Biological Chemistry, 1997
• Identification and characterization of the tuberous sclerosis gene on chromosome 16
  Cell, 1993